Skip to main content
SpringerLink
Log in

Review of hand, foot and mouth disease

  • Review
  • Published:
Frontiers of Medicine in China Aims and scope Submit manuscript

Abstract

Hand, foot and mouth disease (HFMD) is an acute viral illness that primarily affects infants and young children, and often occurs in clusters or outbreaks. The major causative agents of HFMD are coxsackievirus A16 (CVA16), human enterovirus 71 (HEV71) and coxsackievirus A10 (CVA10), of the genus Enterovirus in the family Picornaviridae. HFMD caused by EV71 is associated with severe neurological complications and death. Since the late 1990s, several major epidemics of EV71 HFMD have swept through the Asia-Pacific region, associated with a rapid fulminant course, severe neurological complications, and a large number of fatalities. Until now, little has been known about the genetics and transmission trends of the fast-mutation virus, and there is no effective and specific antiviral therapy or vaccine for HFMD. It is time to step up efforts to understand the molecular epidemics and pathogenesis so that we can develop effective management strategies and surveillance programs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yan J J, Su I J, Chen P F, Liu C C, Yu C K, Wang J R. Complete genome analysis of enterovirus 71 isolated from an outbreak in Taiwan and rapid identification of enterovirus 71 and coxsackievirus A16 by RT-PCR. J Med Virol, 2001, 65(2): 331–339

    Article  CAS  PubMed  Google Scholar 

  2. Bible J M, Pantelidis P, Chan P K, Tong C Y. Genetic evolution of enterovirus 71: epidemiological and pathological implications. Rev Med Virol, 2007, 17(6): 371–379

    Article  CAS  PubMed  Google Scholar 

  3. Schmidt N J, Lennette E H, Ho H H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis, 1974, 129(3): 304–309

    CAS  PubMed  Google Scholar 

  4. Deibel R, Gross L L, Collins D N. Isolation of a new enterovirus (38506). Proc Soc Exp Biol Med, 1975, 148(1): 203–207

    CAS  PubMed  Google Scholar 

  5. Blomberg J, Lycke E, Ahlfors K, Johnsson T, Wolontis S, von Zeipel G. Letter: New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease. Lancet, 1974, 2(7872): 112

    Article  CAS  PubMed  Google Scholar 

  6. Tagaya I, Tachibana K. Epidemic of hand, foot and mouth disease in Japan, 1972–1973: difference in epidemiologic and virologic features from the previous one. Jpn J Med Sci Biol, 1975, 28(4): 231–234

    CAS  PubMed  Google Scholar 

  7. Gilbert G L, Dickson K E, Waters M J, Kennett M L, Land S A, Sneddon M. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J, 1988, 7(7): 484–488

    Article  CAS  PubMed  Google Scholar 

  8. Shindarov L M, Chumakov M P, Voroshilova M K, Bojinov S, Vasilenko S M, Iordanov I, Kirov I D, Kamenov E, Leshchinskaya E V, Mitov G, Robinson I A, Sivchev S, Staikov S. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol, 1979, 23(3): 284–295

    CAS  PubMed  Google Scholar 

  9. Nagy G, Takatsy S, Kukan E, Mihaly I, Domok I. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol, 1982, 71(3): 217–227

    Article  CAS  PubMed  Google Scholar 

  10. World Health Organization. Outbreak of hand, foot and mouth disease in Sarawak. Cluster of deaths among infants and young children. Wkly Epidemiol Rec, 1997, 72(28): 211–212

    Google Scholar 

  11. Lin T Y, Chang L Y, Hsia S H, Huang Y C, Chiu C H, Hsueh C, Shih S R, Liu C C, Wu M H. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis, 2002, 34 Suppl 2: S52–57

    Article  PubMed  Google Scholar 

  12. Shimizu H, Utama A, Onnimala N, Li C, Li-Bi Z, Yu-Jie M, Pongsuwanna Y, Miyamura T. Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int, 2004, 46(2): 231–235

    Article  PubMed  Google Scholar 

  13. AbuBakar S, Chee H Y, Al-Kobaisi M F, Xiaoshan J, Chua K B, Lam S K. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res, 1999, 61(1): 1–9

    Article  CAS  PubMed  Google Scholar 

  14. Lum L C, Wong K T, Lam S K, Chua K B, Goh A Y, Lim W L, Ong B B, Paul G, AbuBakar S, Lambert M. Fatal enterovirus 71 encephalomyelitis, J Pediatr, 1998, 133(6): 795–798

    Article  CAS  PubMed  Google Scholar 

  15. Qiu J. Viral outbreak in China tests government efforts. Nature, 2009, 458(7238): 554–555

    Article  CAS  PubMed  Google Scholar 

  16. Li L, He Y, Yang H, Zhu J, Xu X, Dong J, Zhu Y, Jin Q. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People’s Republic of China. J Clin Microbiol, 2005, 43(8): 3835–3839

    Article  CAS  PubMed  Google Scholar 

  17. Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, He Y, Bu G, Zhou S, Wang J, Qi J. Enterovirus 71 outbreak in the People’s Republic of China in 2008. J Clin Microbiol, 2009, 47(7): 2351–2352

    Article  PubMed  Google Scholar 

  18. http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohbgt/s3582/200903/39757.htm (in Chinese)

  19. http://gov.rednet.cn/c/2009/04/10/1742172.htm (in Chinese)

  20. Brown B A, Oberste M S, Alexander J P Jr, Kennett M L, Pallansch M A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol, 1999, 73(12): 9969–9975

    CAS  PubMed  Google Scholar 

  21. McMinn P, Lindsay K, Perera D, Chan H M, Chan K P, Cardosa M J. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol, 2001, 75(16): 7732–7738

    Article  CAS  PubMed  Google Scholar 

  22. Tong C, Bible J. Global epidemiology of Enterovirus 71. Future Virol, 2009, 4(5): 501–510

    Article  Google Scholar 

  23. Zhang Y, Tan X J, Wang H Y, Yan D M, Zhu S L, Wang D Y, Ji F, Wang X J, Gao Y J, Chen L, An H Q, Li D X, Wang S W, Xu A Q, Wang Z J, Xu W B. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol, 2009, 44(4): 262–267

    Article  PubMed  Google Scholar 

  24. Huang S C, Hsu Y W, Wang H C, Huang S W, Kiang D, Tsai H P, Wang S M, Liu C C, Lin K H, Su I J, Wang J R. Appearance of intratypic recombination of enterovirus 71 in Taiwan from 2002 to 2005. Virus Res, 2008, 131(2): 250–259

    Article  CAS  PubMed  Google Scholar 

  25. Yoke-Fun C, AbuBakar S. Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes. BMC Microbiol, 2006, 6: 74

    Article  PubMed  CAS  Google Scholar 

  26. Ding N Z, Wang X M, Sun S W, Song Q, Li S N, He C Q. Appearance of mosaic enterovirus 71 in the 2008 outbreak of China. Virus Res, 2009, 145(1): 157–161

    Article  CAS  PubMed  Google Scholar 

  27. Ho H Y, Cheng M L, Weng S F, Chang L, Yeh T T, Shih S R, Chiu D T. Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection. J Gen Virol, 2008, 89(Pt 9): 2080–2089

    Article  CAS  PubMed  Google Scholar 

  28. Chang L Y, Chang I S, Chen W J, Huang Y C, Chen G W, Shih S R, Juang J L, Shih H M, Hsiung C A, Lin T Y, Huang L M. HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics, 2008, 122(6): 1271–1276

    Article  PubMed  Google Scholar 

  29. Huemer H P, Ortner B, Huang C W, Schmid D, Mutz I, Wewalka G, Yang J Y, Allerberger F. Isolating Asian enterovirus 71 subgenogroup C4 in two Austrian clinical samples from 2004. Euro Surveill, 2008, 13(28): pii: 18922

    Google Scholar 

  30. Zhang Y, Tan X J, Wang H Y, Yan D M, Zhu S L, Wang D Y, Ji F, Wang X J, Gao Y J, Chen L, An H Q, Li D X, Wang S W, Xu A Q, Wang Z J, Xu W B. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol, 2009, 44(4): 262–267

    Article  PubMed  Google Scholar 

  31. Qiu J. Enterovirus 71 infection: a new threat to global public health? Lancet Neurol, 2008, 7(10): 868–869

    Article  PubMed  Google Scholar 

  32. Chen L C, Shyu H W, Chen S H, Lei H Y, Yu C K, Yeh T M. Enterovirus 71 infection induces Fas ligand expression and apoptosis of Jurkat cells. J Med Virol, 2006, 78(6): 780–786

    Article  CAS  PubMed  Google Scholar 

  33. Chang S C, Lin J Y, Lo L Y, Li M L, Shih S R. Diverse apoptotic pathways in enterovirus 71-infected cells. J Neurovirol, 2004, 10(6): 338–349

    Article  CAS  PubMed  Google Scholar 

  34. Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med, 2009, 15(7): 798–801

    Article  CAS  PubMed  Google Scholar 

  35. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med, 2009, 15(7): 794–797

    Article  CAS  PubMed  Google Scholar 

  36. Lin T Y, Chang L Y, Hsia S H, Huang Y C, Chiu C H, Hsueh C, Shih S R, Liu C C, Wu M H. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis, 2002, 34(Suppl 2): S52–57

    Article  PubMed  Google Scholar 

  37. Chang L Y, Hsia S H, Wu C T, Huang Y C, Lin K L, Fang T Y, Lin T Y. Outcome of enterovirus 71 infections with or without stagebased management: 1998 to 2002. Pediatr Infect Dis J, 2004, 23(4): 327–332

    Article  PubMed  Google Scholar 

  38. Chang LY, Lin T Y, Hsu K H, Huang Y C, Lin K L, Hsueh C, Shih S R, Ning H C, Hwang M S, Wang H S, Lee C Y. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet, 1999; 354(9191): 1682–1686

    Article  CAS  PubMed  Google Scholar 

  39. Wang S M, Lei H Y, Huang M C, Su L Y, Lin H C, Yu C K, Wang J L, Liu C C. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol, 2006, 37(1): 47–52

    Article  CAS  PubMed  Google Scholar 

  40. Wang S M, Lei H Y, Huang M C, Wu J M, Chen C T, Wang J N, Wang J R, Liu C C. Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatr Pulmonol, 2005, 39(3): 219–223

    Article  PubMed  Google Scholar 

  41. Chang L Y. Enterovirus 71 in Taiwan. Pediatr Neonatol, 2008, 49 (4): 103–112

    Article  PubMed  Google Scholar 

  42. Chen T C, Weng K F, Chang S C, Lin J Y, Huang P N, Shih S R. Development of antiviral agents for enteroviruses. J Antimicrob Chemother, 2008, 62(6): 1169–1173

    Article  CAS  PubMed  Google Scholar 

  43. Pevear D C, Tull T M, Seipel M E, Groarke J M. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother, 1999, 43(9): 2109–2115

    CAS  PubMed  Google Scholar 

  44. Shia K S, Li W T, Chang C M, Hsu M C, Chern J H, Leong M K, Tseng S N, Lee C C, Lee Y C, Chen S J, Peng K C, Tseng H Y, Chang Y L, Tai C L, Shih S R. Design, synthesis, and structureactivity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors. J Med Chem, 2002, 45(8): 1644–1655

    Article  CAS  PubMed  Google Scholar 

  45. Li Z H, Li C M, Ling P, Shen F H, Chen S H, Liu C C, Yu C K. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis, 2008, 197(6): 854–857

    Article  CAS  PubMed  Google Scholar 

  46. Foo D G, Alonso S, Phoon M C, Ramachandran N P, Chow V T, Poh C L. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res, 2007, 125(1): 61–68

    Article  CAS  PubMed  Google Scholar 

  47. Chen H L, Huang J Y, Chu T W, Tsai T C, Hung C M, Lin C C, Liu F C, Wang L C, Chen Y J, Lin M F, Chen C M. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine, 2008, 26(23): 2882–2889

    Article  CAS  PubMed  Google Scholar 

  48. Ooi M H, Solomon T, Podin Y, Mohan A, Akin W, Yusuf M A, del Sel S, Kontol K M, Lai B F, Clear D, Chieng C H, Blake E, Perera D, Wong S C, Cardosa J. Evaluation of different clinical sample types in diagnosis of human enterovirus 71-associated hand-footand-mouth disease. J Clin Microbiol, 2007, 45(6): 1858–1866

    Article  PubMed  Google Scholar 

  49. Perez-Velez C M, Anderson M S, Robinson C C, McFarland E J, Nix W A, Pallansch M A, Oberste M S, Glode M P. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis, 2007, 45(8): 950–957

    Article  PubMed  Google Scholar 

  50. Ooi M H, Wong S C, Mohan A, Podin Y, Perera D, Clear D, del Sel S, Chieng C H, Tio P H, Cardosa M J, Solomon T. Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis, 2009, 9: 3

    Article  PubMed  Google Scholar 

  51. Chen K T, Chang H L, Wang S T, Cheng Y T, Yang J Y. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998–2005. Pediatrics, 2007, 120(2): e244–252

    Article  PubMed  Google Scholar 

  52. Podin Y, Gias E L, Ong F, Leong Y W, Yee S F, Yusof M A, Perera D, Teo B, Wee T Y, Yao S C, Yao S K, Kiyu A, Arif M T, Cardosa M J. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health, 2006, 6: 180

    Article  PubMed  Google Scholar 

  53. Chen S C, Chang H L, Yan T R, Cheng Y T, Chen K T. An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg, 2007, 77(1): 188–191

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China

    Lan-Juan Li

Authors
  1. Lan-Juan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lan-Juan Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, LJ. Review of hand, foot and mouth disease. Front. Med. China 4, 139–146 (2010). https://doi.org/10.1007/s11684-010-0033-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-010-0033-6

Keywords

Search

Navigation